×

Dohmen Life Science Services Acquires Chicago Company Focused on Rare Disease Marketing

MILWAUKEE, Jan. 6, 2015 (GLOBE NEWSWIRE) -- Dohmen Life Science Services, a provider of outsourced business services for biopharma and medtech innovators, announced today it has acquired Siren Interactive Corporation, a rare disease relationship marketing company located in Chicago, IL. The acquisition will further expand Dohmen's market leading direct to patient service model, by helping life science companies in the rare disease space locate, educate and interact with the patients they serve.

"Healthcare is shifting from a one size fits all model driven by volume, to a more precise and bespoke care model driven by value. We created and launched DLSS as a platform for life science innovators to reach smaller, more targeted patient populations in the most direct and interactive way possible. We did it because 30 million patients in the US are afflicted with 7000 rare diseases, yet given the historically high cost of developing and commercializing blockbuster therapies, only a few hundred of these diseases have any available treatment," said Cynthia LaConte, CEO, Dohmen Life Science Services. "We believe that people living with a rare disease deserve a more efficient and effective service model; one that accelerates access to care and empowers the healthiest, most productive life possible"

"Siren shares our desire to drive innovation by helping life science innovators reach people suffering from rare disease," said LaConte. "Whether in development, diagnosis or day to day care, there are unique challenges faced by this community. Siren understands these complexities and has overcome them by successfully connecting rare disease patients with lifescience innovators for more than 15 years."

Siren founder and CEO, Wendy White, will join Dohmen as Senior Vice President of their Rare Disease segment. White created her company as a result of her own personal struggle with a family member's rare disease experience. "Dohmen shares our commitment to improving the quality of life for people with rare disease," said White. "Our communications and marketing capability combined with Dohmen's expertise in finance, technology, supply chain, medical and regulatory affairs and patient support services, has the power to really revolutionize the way products and services are developed and delivered to this unique community. The Siren team is excited about joining a company with such a rich tradition of innovation and helping to create a brand new patient care model."

About Dohmen Life Science Services

Intelligent outsourcing for the life sciences.TM Dohmen Life Science Services provides outsourced insight and infrastructure to entrepreneurs seeking speed, scale and certainty as they bring their biopharma or medical device products to market. Our industry experts help hundreds of companies preserve capital, mitigate risk and stay focused on the future by supplying the very best people, processes and tools within the areas of finance, technology, quality, regulatory compliance, supply chain, customer services and patient support. Dohmen Life Science Services is a subsidiary of the Dohmen Company. Privately held and headquartered in Milwaukee, Wisconsin, Dohmen has been finding ways to create a more efficient, effective and accessible healthcare supply system since 1858. More information can be found at DLSS.com and Dohmen.com.

About Siren

Siren Interactive is a rare disease marketing agency with unmatched expertise in addressing the challenges and unmet needs of patients, caregivers, and physicians dealing with the over 7,000 rare diseases affecting over 300 million people worldwide. For more than 15 years, across more than 30 different disease states, we've had 1 focus: Finding rare disease patients and connecting them to our clients' brands. As trailblazers in recognizing that patient-driven decision making is central to successful orphan drug commercialization, we are constantly innovating to meet patients and caregivers where they live. To learn more about our proprietary approaches to building trust relationships with rare disease stakeholders visit sireninteractive.com. Siren Interactive is a subsidiary of Dohmen Life Science Services. More information can be found at DLSS.com.

CONTACT: Kirsten Corbell kirsten.corbell@dlss.com Cell: 414.255.4709Source: Dohmen